, (relating to Figure 1 ). Exposure to hypoxia (<0.1% O 2 ) leads to ATMmediated signaling in S-phase in the absence of detectable DNA damage. Inhibition of ATM activity leads to increased loss of viability in hypoxia (A) RKO cells were exposed to hypoxia (<0.1% O 2 ) for 6 h or NCS (200 ng/ml -6 h). Cells were then fixed and stained as indicated. The hypoxic cells were fixed in hypoxic conditions with equilibrated solutions to avoid reoxygenation. Figure S2 (relating to Figure 2 ). Hypoxia-induced chromatin changes. Hypoxiainduced H3K9me3 is required for ATM activity (A) RKO cells were treated with either Norm (21% O 2 ); Hyp (6 h, <0.1% O 2 ) or IR (5 Gy, cells fixed immediately post IR). Cells were then stained for H3K9me3 and for DNA content using propidium iodide (PI) and analysed using FACS. (B) Chromatin fractionation experiments were carried out with RKO cells exposed to Norm (21% O 2 ) or Hyp (<0.1% O 2 -6 h). Fraction I corresponds to the whole cell extract (WCE) and IV corresponds to the most stringent nuclear fraction. Shown is a WB with H3K9me3 used as a nuclear fraction control. (C) RKO cells were exposed to 0, 6, 18 h of <0.1% O 2 , Reox (6 h, <0.1% O 2 followed by 1 h of 21% O 2 ); or IR (5 Gy, cells harvested 30 minutes post-IR). WB was carried out. Quantification of bands (as fold induction): SETDB1: 6 h = 6.46, 18 h = 4.57, Reox = 0.87; Suv39h2: 6 h =1.39, 18 h = 1.75, Reox = 1.96, IR = 1.81; Suv39h1: 6 h =0.78, 18h = 1.16, Reox = 0.81, IR = 0.36. (D) The mRNA levels of Suv39h1, Suv39h2, SETDB1 and as control GLUT1 were measured by qRT-PCR in RKO cells exposed to either <0.1% O 2 or (E) 2% O 2 . The reox sample was exposed to the relevant oxygen concentration for 6 h and then 21% O 2 for 2 h. (F) Calu6 cells were exposed to 0, 6, 24 h of <0.1% O 2 , Reox (6 h, <0.1% O 2 followed by 1 h of 21% O 2 ); IR (5 Gy, cells fixed 30 minutes post IR). WB was carried out. (G) RKO cells were treated with KAP-1 or Scramble siRNA and exposed to 0, 6, 18 h of <0.1% O 2 . WB was carried out as indicated. The low and high exposure of H3K9me3 bands is also shown. (H) Quantification of the pATM/actin and H3K9me3/actin ratio. pATM = ATM-1981. (I) Suv39h1/2 +/+ and Suv39h1/2 -/-MEFs were treated as indicated. The ATM-S1987 antibody used was produced from a synthetic peptide corresponding to amino acids [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] . β-tubulin = loading control. (J) Suv39h1/2 +/+ and Suv39h1/2 -/-MEFs were treated as indicated. WB was carried out. IR = 5 Gy, cells harvested immediately post IR. β-tubulin = loading control. (K) RKO cells were treated with or without shSuv39h1/2 and exposed to 0, 2 or 6 h of <0.1% O 2. WB was carried out. (L) The mRNA levels of WIP1 and PP2A-C were assessed by qRT-PCR in Suv39h1/2 +/+ and (M) Suv39h1/2 -/-MEFs following exposure to hypoxia (<0.1% O 2 ) for the times indicated. Fold change is expressed relative to the level of expression in Suv39h1/2 +/+ cells. (N) UCSC genome browser profile of the region of PP2A-C with moderate H3K9me3 binding. (O) RKO cells were exposed to either Norm (21% O 2 ) or Hyp (<0.1% O 2 -6 h). The enrichment of H3K9me3 at the loci on PP2A-C was assessed by ChIP. A representative graph from three independent experiments is shown. (P) RKO cells were exposed to either Norm (21% O 2 ) or Hyp (<0.1% O 2 -6h). The enrichment of H3K9me3 on PP2A-C was assessed by ChIP. Primers were designed to target a region of minimal H3K9me3 enrichment. (Q) RKO cells were exposed to 0 or 6 h of <0.1% O 2 . Analysis of chromatin compaction levels was performed using the EpiQ assay. Chromatin accessibility was compared to the constitutively accessible GAPDH region. *=p<0.05. (R) mRNA levels of PP2A-C were assessed following exposure of RKO cells to either 0, 6, 18 h of hypoxia (<0.1 or 2% O 2 ). mRNA levels for all qRT-PCR were normalized to 18S and expressed as fold change. Error bars indicate error between technical replicates. (S) Phosphatase activity of PP2A-C was determined following treatment of RKO cells with either Norm (21% O 2 ), Hyp (<0.1% O 2 -6 h) or Okadaic acid (OA) (2 h). GAPDH (non-specific antibody), beads plus extract and beads only were used as controls. A representative graph from one of three independent experiments is shown. Error bars indicate the error between technical replicates for the represented experiment. Data are represented as mean +/-SEM. (Peters et al., 2001) . The media in which the pair of D15 Suv39h1/2 -/-and W9 Suv39h1/2 +/+ MEFs were grown was also supplemented with 0.1 mM β-mercaptoethanol. All cell lines were routinely mycoplasma tested and found to be negative. Doxorubicin (Dox) was used at a concentration of 2 μM for 4 hours. Hydroxyurea (Hu) was used at a concentration of 1 mM. ATM inhibitor, KU-55933, (2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one) (Calbiochem) was used at 10 μM. Okadaic acid (OA) (Sigma-Aldrich) was used at a concentration of 0.5 μM for 2 hours. EdU Irradiation. All irradiations were carried out using a Gamma Service® GSR D1 irradiator containing a Cs137 source. The dose rates of the system, as
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determined by the supplier, were 1.938 Gy/min and 1.233 Gy/min depending on the distance from the source.
Immunoblotting. Cells were lysed in UTB (9 M urea, 75 mM Tris-HCl pH 7.5 and 0.15 M β-mercaptoethanol) and sonicated briefly. Antibodies used were CHK2-T68, p53-S15, H3K9me2, KAP1-S824, (Bethyl), ATM-S1981
(Epitomics), ATM-S1981(Rockland), β-actin (Santa Cruz), H2AX and and treated while in G 1 phase (Hammond et al., 2002) . EdU labeling and costaining was carried out according to the manufacturer's instructions (Invitrogen). Cells were visualized using a Bio-Rad Radiance or LSM780 (Carl Zeiss Microscopy Ltd) confocal microscope.
Alkaline Comet Assay. Comet assays were performed as previously (Parsons et al., 2012) , with modifications to allow hypoxic treatments. All
solutions used for hypoxic treatment were equilibrated at indicated oxygen tensions. 6.5 x 10 4 cells were seeded and allowed to adhere for 12 hours, before exposing them to the indicated treatments. Treated cells were trypsinized and embedded in 1% low-melting agarose. Lysis buffer (2.5 M NaCl, 100 mM EDTA disodium salt, 10 mM Tris base, pH 10.5) was then added for an hour at room temperature in the dark. For hypoxic samples lysis was carried out under hypoxic conditions. Slides were removed and washed, followed by incubation in cold electrophoresis buffer (300 mM NaOH, 1 mM EDTA and 1% DMSO, pH > 13) for 30 minutes. Electrophoresis was carried out at 25 V, 300 mA for 25 minutes. Slides were stained with SYBR gold 
Identification of Proteins on Nascent DNA (iPOND).
This procedure was carried out as previously described with some modifications (Sirbu et al., 2012) . In brief, 6-7 x 10 8 cells were used per condition. For cells exposed to hypoxia EdU (10 M) was added immediately before placing the cells in the chamber. Those cells allowed to reoxygenate before crosslinking and harvesting were treated with EdU as soon as they were taken out of the chamber and for the whole duration of the reoxygenation period (2 hours). For cells exposed to normoxia EdU was added for 1 hour before crosslinking and harvesting ( Figure S3 ).
Single-molecule DNA fiber analysis. DNA fibers were generated as previously described (Pires et al., 2010; Wilsker et al., 2008) . Images of fiber spreads were taken by using a Bio-Rad Radiance or LSM780 (Carl Zeiss Microscopy Ltd) confocal microscope and analyzed using ImageJ software (NIH). At least 50-100 tracks were scored per condition. were formalin fixed and paraffin embedded.
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Immunohistochemistry staining (IHC). IHC analysis was performed on 4 μm sections of paraffin-embedded Calu6 xenografts as described with a few modifications (Bottini et al., 2000) . 

SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Neutral comet assay. 0.65 x 10 5 RKO cells were plated in glass petri dishes and allowed to adhere for 12 hours. Cells were embedded as described for alkaline comet assay. Coated slides were submerged into lysis buffer pH 8.3
(30 mM EDTA, 0.5% sodium dodecyl sulphate, 0.5 mg/ml Proteinase-K) for 16 hours in the dark at 37°C (4°C for 2 h and then transferred to 37°C for IR studies). For hypoxic studies all the slides were incubated at 37°C inside the hypoxic chamber with pre-equilibrated solutions. Following lysis, the slides were rinsed with TBE buffer pH 8. 
Chromatin immunoprecipitation (ChIP).
ChIP was carried out as described (Bindra et al., 2005) . 3 μg H3 and 6 μg H3K9me3 antibodies (Abcam) were used for immunoprecipitation. Rabbit pre-immune serum was used as an IgG control. A no antibody control sample was also included in each experiment. qRT-PCR was carried out as described above with the primers stated in the supplemental information. Immunoprecipitation samples were diluted 1:6 and input was diluted 1:100 for qRT-PCR analysis. Fold enrichment is expressed as a % of input and is normalized to total H3 in each sample.
qRT-PCR. RNA was extracted using Trizol (Invitrogen/Life Technologies).
Verso (Thermo Scientific) or SuperScript
Technologies) cDNA synthesis kits were used to reverse transcribe cDNA from total RNA according to manufacturer's instructions. Quantitative real time PCR was performed as previously using the Thermo Scientific Verso™ qRT-
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PCR following manufacturers recommendations (Pires et al., 2010) .
Reactions were carried out in a 7500 Fast real time PCR detection system (Applied Biosystems). mRNA fold change levels were normalized to 18S ribosomal RNA and calculated using a 2 -ΔΔCt method. Error bars indicate the error between three technical replicates ± RQ max and RQ min from one experiment.
Phosphatase assay. This assay was carried out according to the manufacturer's instructions (Millipore) with a few modifications. In brief, extracts were prepared in such a way as to ensure minimal phosphate content of the extracts (Tanaka et al., 1992) . Cell extracts were resuspended in one 
EpiQ Chromatin analysis
RKO cells were seeded at a concentration of 3 x 10 5 cells/ml in a 48-well plate, allowed to attach overnight and exposed to 6h of <0.1% O 2 .
Quantitative assessment of chromatin structure was performed using an EpiQ chromatin analysis assay (Bio-Rad Laboratories) according to the manufacturer's protocol. The qRT-PCR primers used as controls for CCCGCCTGAAGTCTCTGATTAA -3′) (Addgene plasmid 36394) were used (we thank George Daley for depositing these plasmids in Addgene). RKO cells were transduced with shRNA lentiviruses as previously described (Onder et al., 2012) . Twenty-four hours after the last infection, cells were washed extensively and grown in medium containing 1 μg/ml puromycin.
Biochemical fractionation.
Fractionation was carried out as described in (Andegeko et al., 2001) . Fractionation was carried out in four consecutive steps with the supernatant being collected at each stage. Fractions I and II were fractionated in Nonidet P-40 buffer (containing 50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.2% Nonidet P-40). 0.5% Nonidet P-40 buffer was used to fractionate fraction III. Protease (complete EDTA free; Roche) and phosphatase (Phospho-Stop; Roche) inhibitors were added to all buffers.
For fraction IV, harvested cells were lysed in 1 X SDS-PAGE sample buffer.
Equal aliquots of each fraction corresponding to 1/5 th of the total sample 
